Broad Institute Bond Issue Seeks to Raise $353M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Broad Institute of Harvard and MIT plans to sell up to $353.4 million in bonds to help finance the building of a new biomedical research lab in Cambridge, Mass.

The bonds will be issued by the Massachusetts Development Finance agency and will include $269.9 million in tax exempt Series 2011A revenue bonds and $83.5 million in taxable Series 2011B revenue bonds, a spokesperson for the Broad confirmed Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.